Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


With Legislation In Balance, IRS Gives Temporary Relief From Device Tax Penalty

Executive Summary

The Internal Revenue Services will hold off penalizing medical device-makers for late payments of the device tax for the first three quarters of the year, after lobbying from industry and lawmakers.

You may also be interested in...

US Congress Ends Shutdown, Clinches Two-Year Device-Tax Repeal

Congress reached agreement Jan. 22 to end the three-day US government shutdown in a continuing resolution bill that includes a two-year device-tax suspension.

US House Votes To Delay Device Tax For Two Years As Part Of Budget Deal

The US House of Representatives agreed Jan.18 to delay implementation of the medical device excise tax for another two years, until January 2020. The delay is part of a continuing resolution to fund the government until Feb. 16, and support the Children's Health Insurance Program for six more years. Industry groups are jubilant at the tax reprieve, but the budget plan also needs Senate approval.

Hello Device Tax, We Hardly Missed You: Companies Seek IRS Action To Stall Tax

With congressional options exhausted for 2017, industry hopes for IRS relief from the device-tax reality, either with a temporary waiver of deposit penalties or some broader tax-enforcement delay.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts